Is it safe to combine Wellbutrin (bupropion) and Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Combining Wellbutrin (Bupropion) and Lexapro (Escitalopram)

Yes, combining Wellbutrin (bupropion) and Lexapro (escitalopram) is generally safe and can be an effective treatment strategy for depression. 1

Evidence for Safety and Efficacy

  • Bupropion and escitalopram have different mechanisms of action, with bupropion affecting dopaminergic and noradrenergic systems while escitalopram is a selective serotonin reuptake inhibitor (SSRI) 1
  • Clinical guidelines indicate that augmenting an SSRI (like escitalopram) with bupropion is a recognized treatment strategy for patients with depression 1
  • Low-quality evidence from clinical trials shows that augmenting citalopram (similar to escitalopram) with bupropion can decrease depression severity more than augmentation with buspirone 1
  • Moderate-quality evidence indicates that discontinuation due to adverse events was actually lower with bupropion than with buspirone when used as augmentation therapy 1

Advantages of This Combination

  • Bupropion has a lower risk of sexual side effects compared to other antidepressants, which can help counteract the sexual dysfunction commonly associated with SSRIs like Lexapro 1
  • The combination may provide more comprehensive neurotransmitter coverage by targeting both serotonergic (escitalopram) and dopaminergic/noradrenergic (bupropion) systems 2
  • For treatment-resistant depression, combination therapy may be more effective than monotherapy in some cases 3

Potential Concerns and Monitoring

  • Both medications can potentially lower the seizure threshold, though this is primarily a concern with bupropion at higher doses 1
  • Bupropion is contraindicated for patients with seizure risks (stroke, brain metastases) 1
  • While rare, there have been case reports of adverse events in special populations (such as an infant exposed through breastfeeding) when both medications were used together 4
  • Careful monitoring for neuropsychiatric symptoms is recommended, although recent large trials have not shown significant increases in these events with either medication 1

Dosing Considerations

  • When used in combination therapy, standard dosing can be maintained:
    • Bupropion: Usually 150-300 mg daily 1
    • Escitalopram: Usually 10-20 mg daily 1
  • Dose adjustments may be needed based on individual response and tolerability 1

Drug Interaction Considerations

  • The combination does not have major pharmacokinetic interactions that would significantly alter blood levels of either medication 5
  • The risk of serotonin syndrome is lower with this combination compared to combining multiple serotonergic agents 5
  • Neither medication should be combined with MAOIs due to risk of hypertensive crisis or serotonin syndrome 1, 5

Clinical Decision Algorithm

  1. Start with either escitalopram or bupropion as monotherapy first
  2. If partial response after adequate trial (4-6 weeks), consider adding the second agent
  3. Monitor closely for side effects during the first few weeks of combination therapy
  4. Assess for improvement in depressive symptoms and any emerging side effects
  5. If both medications are well-tolerated but response remains inadequate, consider alternative strategies 1

This combination is supported by clinical guidelines and can be particularly helpful for patients who have had an inadequate response to SSRI monotherapy or who experience problematic side effects (particularly sexual dysfunction) with SSRIs alone 1, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bupropion and sertraline combination treatment in refractory depression.

Journal of psychopharmacology (Oxford, England), 1995

Research

Bupropion and Escitalopram During Lactation.

The Annals of pharmacotherapy, 2014

Research

Systematic overview of drug interactions with antidepressant medications.

Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.